News
Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.
A team of Ohio State researchers engineered a new antibody that could revolutionize influenza prevention through a nasal ...
Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...
The Motley Fool’s approach to investing prioritises buying and holding quality stocks for long periods of time. The post 4 ...
After the stock market makes a stellar recovery this month, our writer highlights the UK shares he's considering investing in ...
More than 80,000 people globally die every year from snake bites, according to the World Health Organization. But Tim Friede ...
During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant ...
The occurrence of JHR after benzathine penicillin G treatment for early syphilis was positively associated with secondary syphilis and negatively associated with lack of HIV.
The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...
The Royal Oldham Hospital has become the first in the UK to introduce industry leading technology to speed up test results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results